KEGG   COMPOUND: C00027
Entry
C00027                      Compound                               
Name
Hydrogen peroxide;
H2O2;
Oxydol
Formula
H2O2
Exact mass
34.0055
Mol weight
34.0147
Structure
Remark
Same as: D00008
Reaction
R00009 R00011 R00017 R00033 R00052 R00057 R00069 R00072
R00090 R00113 R00120 R00207 R00211 R00250 R00273 R00274
R00275 R00277 R00278 R00279 R00302 R00357 R00359 R00360
R00366 R00388 R00447 R00466 R00475 R00481 R00533 R00602
R00608 R00610 R00612 R00635 R00637 R00643 R00644 R00648
R00677 R00689 R00729 R00799 R00846 R00975 R00993 R01022
R01098 R01099 R01151 R01203 R01259 R01264 R01340 R01341
R01442 R01459 R01469 R01489 R01491 R01522 R01564 R01609
R01695 R01703 R01709 R01710 R01711 R01769 R01851 R01853
R01910 R01914 R01962 R02106 R02107 R02125 R02132 R02150
 » show all
Pathway
map00630  Glyoxylate and dicarboxylate metabolism
map01110  Biosynthesis of secondary metabolites
map04022  cGMP-PKG signaling pathway
map04210  Apoptosis
map04216  Ferroptosis
map04217  Necroptosis
map04218  Cellular senescence
map04380  Osteoclast differentiation
map04613  Neutrophil extracellular trap formation
map04624  Toll and Imd signaling pathway
map04625  C-type lectin receptor signaling pathway
map04626  Plant-pathogen interaction
map04670  Leukocyte transendothelial migration
map04918  Thyroid hormone synthesis
map04940  Type I diabetes mellitus
map05010  Alzheimer disease
map05012  Parkinson disease
map05014  Amyotrophic lateral sclerosis
map05020  Prion disease
map05022  Pathways of neurodegeneration - multiple diseases
map05030  Cocaine addiction
map05031  Amphetamine addiction
map05034  Alcoholism
map05146  Amoebiasis
map05164  Influenza A
map05166  Human T-cell leukemia virus 1 infection
map05171  Coronavirus disease - COVID-19
map05200  Pathways in cancer
map05204  Chemical carcinogenesis - DNA adducts
map05208  Chemical carcinogenesis - reactive oxygen species
map05225  Hepatocellular carcinoma
map05322  Systemic lupus erythematosus
map05415  Diabetic cardiomyopathy
map05417  Lipid and atherosclerosis
Module
M00532  Photorespiration
Network
nt06171  SARS coronavirus 2 (SARS-CoV-2)
nt06226  KEAP1-NRF2 signaling (cancer)
nt06251  CYP-mediated ROS formation (cancer)
nt06263  Hepatocellular carcinoma
nt06322  TRH-TSH-TH signaling
nt06463  Parkinson disease
nt06465  Prion disease
Enzyme
1.1.3.2         1.1.3.4         1.1.3.5         1.1.3.6         
1.1.3.7         1.1.3.8         1.1.3.9         1.1.3.10        
1.1.3.11        1.1.3.12        1.1.3.13        1.1.3.15        
1.1.3.16        1.1.3.17        1.1.3.18        1.1.3.19        
1.1.3.21        1.1.3.23        1.1.3.27        1.1.3.29        
1.1.3.30        1.1.3.37        1.1.3.38        1.1.3.39        
1.1.3.40        1.1.3.41        1.1.3.42        1.1.3.43        
1.1.3.44        1.1.3.45        1.1.3.46        1.1.3.47        
1.1.3.48        1.1.3.49        1.1.3.50        1.1.3.-         
1.1.5.4         1.1.99.9        1.1.99.18       1.2.3.1         
1.2.3.3         1.2.3.4         1.2.3.5         1.2.3.6         
1.2.3.7         1.2.3.8         1.2.3.9         1.2.3.14        
1.2.3.15        1.2.3.-         1.3.3.4         1.3.3.6         
1.3.3.7         1.3.3.8         1.3.3.10        1.3.3.11        
1.3.3.12        1.3.3.13        1.3.3.14        1.3.3.15        
1.3.3.17        1.3.98.5        1.4.3.1         1.4.3.2         
1.4.3.3         1.4.3.4         1.4.3.5         1.4.3.7         
1.4.3.8         1.4.3.10        1.4.3.11        1.4.3.12        
1.4.3.13        1.4.3.14        1.4.3.15        1.4.3.16        
1.4.3.19        1.4.3.20        1.4.3.21        1.4.3.22        
1.4.3.23        1.4.3.25        1.4.3.26        1.4.3.27        
1.4.3.-         1.4.9.2         1.5.3.1         1.5.3.2         
1.5.3.4         1.5.3.5         1.5.3.6         1.5.3.7         
1.5.3.10        1.5.3.12        1.5.3.13        1.5.3.14        
1.5.3.15        1.5.3.16        1.5.3.17        1.5.3.18        
1.5.3.19        1.5.3.21        1.5.3.24        1.5.3.25        
1.5.3.26        1.5.3.-         1.5.99.6        1.6.3.1         
1.6.3.3         1.6.3.5         1.7.3.1         1.7.3.3         
1.7.3.5         1.8.3.1         1.8.3.2         1.8.3.3         
1.8.3.4         1.8.3.5         1.8.3.6         1.10.3.5        
1.10.3.6        1.10.3.16       1.11.1.1        1.11.1.2        
1.11.1.3        1.11.1.5        1.11.1.6        1.11.1.7        
1.11.1.8        1.11.1.9        1.11.1.10       1.11.1.11       
1.11.1.13       1.11.1.14       1.11.1.16       1.11.1.17       
1.11.1.18       1.11.1.19       1.11.1.21       1.11.1.23       
1.11.2.1        1.11.2.2        1.11.2.4        1.11.2.5        
1.11.2.6        1.14.13.-       1.15.1.1        1.15.1.2        
1.16.3.2        1.17.3.2        1.17.3.3        1.21.3.3        
1.21.3.7        1.21.3.8        4.1.1.107       4.1.1.108       
4.1.1.109       4.99.1.-
 » show all
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A01 STOMATOLOGICAL PREPARATIONS
   A01A STOMATOLOGICAL PREPARATIONS
    A01AB Antiinfectives and antiseptics for local oral treatment
     A01AB02 Hydrogen peroxide
      D00008  Hydrogen peroxide (USP) <JP>
 D DERMATOLOGICALS
  D08 ANTISEPTICS AND DISINFECTANTS
   D08A ANTISEPTICS AND DISINFECTANTS
    D08AX Other antiseptics and disinfectants
     D08AX01 Hydrogen peroxide
      D00008  Hydrogen peroxide (USP) <JP>
  D11 OTHER DERMATOLOGICAL PREPARATIONS
   D11A OTHER DERMATOLOGICAL PREPARATIONS
    D11AX Other dermatologicals
     D11AX25 Hydrogen peroxide
      D00008  Hydrogen peroxide (USP) <JP>
 S SENSORY ORGANS
  S02 OTOLOGICALS
   S02A ANTIINFECTIVES
    S02AA Antiinfectives
     S02AA06 Hydrogen peroxide
      D00008  Hydrogen peroxide (USP) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  26  Epidermides
   261  Antimicrobial agents
    2614  Peroxides
     D00008  Hydrogen peroxide (USP); Oxydol (JP18)
Classification of Japanese OTC drugs [BR:br08313]
 Agents for integumentary system
  54 Disinfectants (incl. special bandages)
   D00008  Hydrogen peroxide (USP)
Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
  Inorganic and organic chemicals
   Oxydol
    D00008  Hydrogen peroxide (USP)
Animal drugs in Japan [BR:br08331]
 95  Agents for external use
  954  Anti-dermoinfectives
   9549  Other anti-dermoinfectives
    C00027  Hydrogen peroxide
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D00008  Oxydol
Other DBs
CAS: 7722-84-1
PubChem: 3329
ChEBI: 16240
PDB-CCD: PEO[PDBj]
NIKKAJI: J98.262H
LinkDB
KCF data

ATOM        2
            1   O1a O    29.6100  -14.4200
            2   O1a O    31.0100  -14.4200
BOND        1
            1     1   2 1

» Japanese version

DBGET integrated database retrieval system